Collectively, our results are consistent with the hypothesis that E1A expression in tumors may preserve antigen-specific anti-tumor T cell responses in the local tumor environment by inhibiting the production of arginase-1 by TAMs, a biological activity of E1A not previously described. The gene discussed is ARG1; the disease is neoplasm.